Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexandra Grosse

Lung Adenocarcinoma Manifesting With Lymphangitic Spread and Psammoma Bodies, Harboring a HER2 Exon 20 Insertion Mutation (p.A745_G746insYVMA)

Journal of Thoracic Oncology

English

Related publications

RET-Rearranged Lung Adenocarcinomas With Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib

Journal of Thoracic Oncology

English

P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.

Journal of Thoracic Oncology

English

P3.01-96 Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 of EGFR or HER2

Journal of Thoracic Oncology

English

Triple Mutation Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719S), 20 (T790M) and 21 (L858R) in a Male Patient With Lung Adenocarcinoma: A Case Report

Jurnal Respirasi

2020

English

P2.13-42 Osimertinib Treatment for Patients With EGFR Exon 20 Insertion Positive Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.13-42 Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

Journal of Thoracic Oncology

English

MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology

English

An Autopsy Case of Adenocarcinoma of the Lung With Cutaneous Lymphangitic Carcinomatosis.

Japanese Journal of Lung Cancer

English

Characterization of 298 Patients With Lung Cancer Harboring MET Exon 14 Skipping Alterations

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexandra Grosse

Lung Adenocarcinoma Manifesting With Lymphangitic Spread and Psammoma Bodies, Harboring a HER2 Exon 20 Insertion Mutation (p.A745_G746insYVMA)

Related publications

RET-Rearranged Lung Adenocarcinomas With Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib

P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.

P3.01-96 Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 of EGFR or HER2

Triple Mutation Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719S), 20 (T790M) and 21 (L858R) in a Male Patient With Lung Adenocarcinoma: A Case Report

P2.13-42 Osimertinib Treatment for Patients With EGFR Exon 20 Insertion Positive Non-Small-Cell Lung Cancer

P1.13-42 Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors

An Autopsy Case of Adenocarcinoma of the Lung With Cutaneous Lymphangitic Carcinomatosis.

Characterization of 298 Patients With Lung Cancer Harboring MET Exon 14 Skipping Alterations